Antibiotice plans production for critical medicines
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.

Romania's annual inflation rate remained unchanged at 9.8% in November.
Romania leads the European Union in both VAT and corporate tax collection failures, losing approximately one-third of potential revenue from each tax, according to a European Commission analysis published this week.
ABB Romania has opened its new customer experience center in Bucharest, a space designed to showcase the company's solutions in electrification, automation, energy efficiency and motion.
As winter holidays approach, Romanians experience both the joy of gift preparation and the pressure of festive spending.
The Investment Committee designated by the Romanian Government for the Recovery Equity Fund has approved financing for five new investment funds in Q4 2025, announced the Ministry of Investments and European Projects (MIPE).